MENU
LGVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Longeveron (LGVN) Ownership - Who owns Longeveron?

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions... Show more

Profile

Industry
N/A
Address
1951 NW 7th Avenue
Phone
+1 305 909-0840
Employees
25
Web
https://www.longeveron.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.36M
P/E Ratio
2.95
Total Cash
9.24M
Projected Growth
N/A
Total Debt
983K
Revenue
1.44M
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash/Share
0.43
Total Debt/Equity
N/A
Revenue/Share
0.09 USD as % of share price

Fundamentals

LGVN
Capitalization
11.4M
P/E Ratio
2.95
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash
9.24M
Total Cash/Share
0.43
Total Debt
983K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.09%
Revenue
1.44M
ROE
N/A
Book Value
9.97M
P/B Ratio
1.14
Cash Flow
N/A
Earnings
-0.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
20K
Current Ratio
2.09
Current Revenue Per Employee
5480.00
Dividends Per Share - Security
N/A
EBITDA
-20.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.24
Revenue To Assets
-93.88
Shares Held By Institutions
740K
Shares Outstanding - Current
21.3M
Total Liabilities
5.59M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-69.225
View a ticker or compare two or three
LGVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1951 NW 7th Avenue
Phone
+1 305 909-0840
Employees
25
Web
https://www.longeveron.com